The team used the AMG1541 LNP to deliver an mRNA influenza vaccine in mice. They compared this vaccine’s effectiveness to a flu vaccine made with the lipid SM-102, which is FDA-approved and was used ...

Approach that uses cell’s own strategy of liquid-liquid phase separation protects synthetic modifications from being washed away by the tide of cell growth.

Intellia Therapeutics has acknowledged the death of the elderly patient hospitalized last week in its Phase III trial of assessing nexiguran ziclumeran (nex-z) in transthyretin amyloidosis with ...

Berry Genomics plans to expand its sequencing capability to clinical assays like congenital adrenal hyperplasia and spinal muscular atrophy.

Engineered human stomach organoids, transplanted into mice, produced insulin-secreting cells, offering a potential new ...

Technology opens the door to more accurate preclinical testing, which could enable the development of safer and more effective therapies.

Abzena and Mabqi bring together two organizations that are focused on advancing antibody innovation through integration.

The company's initial target is immuno-oncology projects but there are plans to expand into autoimmune disease, infectious disease, and more.